Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 5898-5906

  Sebastián, Carlos ^a   Serra, Maria ^a   Yeramian, Andrée ^a   Serrat, Neus ^a   Lloberas, Jorge ^a   Celada, Antonio ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; DEACETYLASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 4; JANUS KINASE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYC PROTEIN; RNA POLYMERASE II; STAT5 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR RELB; TRICHOSTATIN A; UNCLASSIFIED DRUG; CDKN1A PROTEIN, MOUSE; CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HISTONE DEACETYLASE; HLA ANTIGEN CLASS 2; HYDROXAMIC ACID; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; IRF2 PROTEIN, MOUSE; JAK2 PROTEIN, MOUSE; MHC CLASS II TRANSACTIVATOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN, MOUSE; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RELB PROTEIN, MOUSE; STAT5A PROTEIN, MOUSE; STAT5B PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DNA BINDING; ENZYME ACTIVITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PROMOTER REGION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DENDRITIC CELLS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; INTERFERON REGULATORY FACTOR-2; INTERFERON REGULATORY FACTORS; JANUS KINASE 2; MACROPHAGES; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RNA POLYMERASE II; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELB;

EID: 44449083407     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.5898     Document Type: Article

References (63)

1. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12: 599-606. (Pubitemid 28134293)
2. Tyler, J. K., and J. T. Kadonaga. 1999. The "dark side" of chromatin remodeling: repressive effects on transcription. Cell 99: 443-446. (Pubitemid 129746826)
3. Van Lint, C., S. Emiliani, and E. Verdin. 1996. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expression 5: 245-253. (Pubitemid 126682821)
4. Xu, M., L. Nie, S. H. Kim, and X. H. Sun. 2003. STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPβ. EMBO J. 22: 893-904. (Pubitemid 36227791)
5. Cheung, P., and P. Lau. 2005. Epigenetic regulation by histone methylation and histone variants. Mol. Endocrinol. 19: 563-573. (Pubitemid 40349431)
6. Peterson, C. L., and M. A. Laniel. 2004. Histones and histone modifications. Curr. Biol. 14: R546-R551.
7. Razin, A., and B. Kantor. 2005. DNA methylation in epigenetic control of gene expression. Prog. Mol. Subcell. Biol. 38: 151-167.
8. Metcalf, D. 1998. The molecular control of hematopoiesis: progress and problems with gene manipulation. Stem Cells 16 (Suppl. 2): 1-9. (Pubitemid 28455646)
9. Comalada, M., J. Xaus, E. Sanchez, A. F. Valledor, and A. Celada. 2004. Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase/Akt pathway. Eur. J. Immunol. 34: 2257-2267. (Pubitemid 39256107)
10. Hamilton, J. A. 2002. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23: 403-408.
11. Hill, A. D., H. A. Naama, S. E. Calvano, and J. M. Daly. 1995. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J. Leukocyte Biol. 58: 634-642. (Pubitemid 26032382)
12. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
13. Barreda, D. R., P. C. Hanington, and M. Belosevic. 2004. Regulation of myeloid development and function by colony stimulating factors. Dev. Comp. Immunol. 28: 509-554. (Pubitemid 38177451)
14. Dijkers, P. F., T. B. van Dijk, R. P. de Groot, J. A. Raaijmakers, J. W. Lammers, L. Koenderman, and P. J. Coffer. 1999. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor. Oncogene 18: 3334-3342. (Pubitemid 29286979)
15. Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651-662.
16. Shuai, K. 2000. Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19: 2638-2644. (Pubitemid 30339220)
17. Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D'Andrea, and D. M. Livingston. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383: 344-347. (Pubitemid 26321765)
18. Korzus, E., J. Torchia, D. W. Rose, L. Xu, R. Kurokawa, E. M. McInerney, T. M. Mullen, C. K. Glass, and M. G. Rosenfeld. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279: 703-707. (Pubitemid 28144549)
19. Zhang, J. J., U. Vinkemeier, W. Gu, D. Chakravarti, C. M. Horvath, and J. E. Darnell, Jr. 1996. Two contact regions between Stat1 and CBP/p300 in interferon γ signaling. Proc. Natl. Acad. Sci. USA 93: 15092-15096.
20. Nusinzon, I., and C. M. Horvath. 2003. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. USA 100: 14742-14747. (Pubitemid 37517961)
21. Rascle, A., J. A. Johnston, and B. Amati. 2003. Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol. Cell. Biol. 23: 4162-4173. (Pubitemid 36666421)
22. Taddei, A., D. Roche, W. A. Bickmore, and G. Almouzni. 2005. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? EMBO Rep. 6: 520-524. (Pubitemid 40973959)
23. Celada, A., P. W. Gray, E. Rinderknecht, and R. D. Schreiber. 1984. Evidence for a γ-interferon receptor that regulates macrophage tumoricidal activity. J. Exp. Med. 160: 55-74. (Pubitemid 14089780)
24. Sanchez-Tillo, E., M. Wojciechowska, M. Comalada, C. Farrera, J. Lloberas, and A. Celada. 2006. Cyclophilin A is required for M-CSF-dependent macrophage proliferation. Eur. J. Immunol. 36: 2515-2524. (Pubitemid 44420607)
25. Aung, H. T., K. Schroder, S. R. Himes, K. Brion, W. van Zuylen, A. Trieu, H. Suzuki, Y. Hayashizaki, D. A. Hume, M. J. Sweet, and T. Ravasi. 2006. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J. 20: 1315-1327.
26. Celada, A., F. E. Borras, C. Soler, J. Lloberas, M. Klemsz, C. van Beveren, S. McKercher, and R. A. Maki. 1996. The transcription factor PU. 1 is involved in macrophage proliferation. J. Exp. Med. 184: 61-69. (Pubitemid 26247215)
27. Xaus, J., M. Mirabet, J. Lloberas, C. Soler, C. Lluis, R. Franco, and A. Celada. 1999. IFN-γ up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J. Immunol. 162: 3607-3614. (Pubitemid 29313615)
28. Valledor, A. F., J. Xaus, L. Marques, and A. Celada. 1999. Macrophage colony-stimulating factor induces the expression of mitogen-activated protein kinase phosphatase-1 through a protein kinase C-dependent pathway. J. Immunol. 163: 2452-2462. (Pubitemid 29399164)
29. Celada, A., M. Shiga, M. Imagawa, J. Kop, and R. A. Maki. 1988. Identification of a nuclear factor that binds to a conserved sequence of the I-A β gene. J. Immunol. 140: 3995-4002. (Pubitemid 18133144)
30. Brucet, M., L. Marques, C. Sebastian, J. Lloberas, and A. Celada. 2004. Regulation of murine Tap1 and Lmp2 genes in macrophages by interferon γ is mediated by STAT1 and IRF-1. Genes Immun. 5: 26-35. (Pubitemid 38967626)
31. Burgess, A. W., and D. Metcalf. 1980. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56: 947-958. (Pubitemid 11205044)
32. Hornell, T. M., G. W. Beresford, A. Bushey, J. M. Boss, and E. D. Mellins. 2003. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor. J. Immunol. 171: 2374-2383. (Pubitemid 37025544)
33. Comalada, M., A. F. Valledor, E. Sanchez-Tillo, I. Umbert, J. Xaus, and A. Celada. 2003. Macrophage colony-stimulating factor-dependent macrophage proliferation is mediated through a calcineurin-independent but immunophilin- dependent mechanism that mediates the activation of external regulated kinases. Eur. J. Immunol. 33: 3091-3100. (Pubitemid 37428341)
34. Valledor, A. F., M. Comalada, J. Xaus, and A. Celada. 2000. The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation. J. Biol. Chem. 275: 7403-7409. (Pubitemid 30146295)
35. Xaus, J., M. Cardo, A. F. Valledor, C. Soler, J. Lloberas, and A. Celada. 1999. Interferon γ induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 11: 103-113. (Pubitemid 29359961)
36. Geijsen, N., L. Koenderman, and P. J. Coffer. 2001. Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. Cytokine Growth Factor Rev. 12: 19-25. (Pubitemid 32294583)
37. Thompson, J. E. 2005. JAK protein kinase inhibitors. Drug News Perspect. 18: 305-310. (Pubitemid 41491469)
38. Celada, A., and R. A. Maki. 1989. The expression of I-A correlates with the uptake of interferon-γ by macrophages. Eur. J. Immunol. 19: 205-208. (Pubitemid 19069311)
39. Cullell-Young, M., M. Barrachina, C. Lopez-Lopez, E. Gonalons, J. Lloberas, C. Soler, and A. Celada. 2001. From transcription to cell surface expression, the induction of MHC class II I-A α by interferon-γ in macrophages is regulated at different levels. Immunogenetics 53: 136-144. (Pubitemid 32289629)
40. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14: 301-331. (Pubitemid 26130187)
41. Kwon, M. J., J. W. Soh, and C. H. Chang. 2006. Protein kinase Cδ is essential to maintain CIITA gene expression in B cells. J. Immunol. 177: 950-956. (Pubitemid 44036596)
42. Celada, A., M. J. Klemsz, and R. A. Maki. 1989. Interferon-γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A β, tumor necrosis factor, and complement component C3 in mouse macrophages. Eur. J. Immunol. 19: 1103-1109. (Pubitemid 19181163)
43. Casals, C., M. Barrachina, M. Serra, J. Lloberas, and A. Celada. 2007. Lipopolysaccharide up-regulates MHC class II expression on dendritic cells through an AP-1 enhancer without affecting the levels of CIITA. J. Immunol. 178: 6307-6315. (Pubitemid 46717414)
44. Zhang, Q., H. Y. Wang, M. Marzec, P. N. Raghunath, T. Nagasawa, and M. A. Wasik. 2005. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc. Natl. Acad. Sci. USA 102: 6948-6953. (Pubitemid 40675422)
45. Ardavin, C. 2003. Origin, precursors, and differentiation of mouse dendritic cells. Nat. Rev. Immunol. 3: 582-590. (Pubitemid 37328677)
46. Tamura, T., P. Tailor, K. Yamaoka, H. J. Kong, H. Tsujimura, J. J. O'Shea, H. Singh, and K. Ozato. 2005. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174: 2573-2581. (Pubitemid 40279670)
47. + dendritic cells in mice deficient for IFN regulatory factor-2. Proc. Natl. Acad. Sci. USA 101: 3909-3914.
48. Honda, K., T. Mizutani, and T. Taniguchi. 2004. Negative regulation of IFN-αβ signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc. Natl. Acad. Sci. USA 101: 2416-2421. (Pubitemid 38269326)
49. + dendritic cells. Immunity 9: 839-847.
50. Kobayashi, T., P. T. Walsh, M. C. Walsh, K. M. Speirs, E. Chiffoleau, C. G. King, W. W. Hancock, J. H. Caamano, C. A. Hunter, P. Scott, et al. 2003. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 19: 353-363. (Pubitemid 37153412)
51. Rosa Santos, S. C., S. Dumon, P. Mayeux, S. Gisselbrecht, and F. Gouilleux. 2000. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene 19: 1164-1172. (Pubitemid 30157546)
52. Santos, S. C., V. Lacronique, I. Bouchaert, R. Monni, O. Bernard, S. Gisselbrecht, and F. Gouilleux. 2001. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. Oncogene 20: 2080-2090. (Pubitemid 32424002)
53. Nyga, R., C. Pecquet, N. Harir, H. Gu, I. Dhennin-Duthille, A. Regnier, V. Gouilleux-Gruart, K. Lassoued, and F. Gouilleux. 2005. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Biochem. J. 390: 359-366. (Pubitemid 41192263)
54. Harir, N., C. Pecquet, M. Kerenyi, K. Sonneck, B. Kovacic, R. Nyga, M. Brevet, I. Dhennin, V. Gouilleux-Gruart, H. Beug, et al. 2007. Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. Blood 109: 1678-1686. (Pubitemid 46239602)
55. c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14: 4335-4341.
56. Matsumura, I., T. Kitamura, H. Wakao, H. Tanaka, K. Hashimoto, C. Albanese, J. Downward, R. G. Pestell, and Y. Kanakura. 1999. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18: 1367-1377. (Pubitemid 29110320)
57. Lord, J. D., B. C. McIntosh, P. D. Greenberg, and B. H. Nelson. 2000. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J. Immunol. 164: 2533-2541. (Pubitemid 30115483)
58. Sakamoto, S., R. Potla, and A. C. Larner. 2004. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. J. Biol. Chem. 279: 40362-40367. (Pubitemid 39287623)
59. Lehtonen, A., V. Veckman, T. Nikula, R. Lahesmaa, L. Kinnunen, S. Matikainen, and I. Julkunen. 2005. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. J. Immunol. 175: 6570-6579. (Pubitemid 41598899)
60. Bren, G. D., N. J. Solan, H. Miyoshi, K. N. Pennington, L. J. Pobst, and C. V. Paya. 2001. Transcription of the RelB gene is regulated by NF-κB. Oncogene 20: 7722-7733. (Pubitemid 33121945)
61. Place, R. F., E. J. Noonan, and C. Giardina. 2005. HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes IκBα. Biochem. Pharmacol. 70: 394-406. (Pubitemid 40905111)
62. Yin, L., G. Laevsky, and C. Giardina. 2001. Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J. Biol. Chem. 276: 44641-44646. (Pubitemid 37391243)
63. Brogdon, J. L., Y. Xu, S. J. Szabo, S. An, F. Buxton, D. Cohen, and Q. Huang. 2007. Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood 109: 1123-1130. (Pubitemid 46220659)